"Navigating the Modern News Zoo so you don't have to."
Monday, May 19, 2025
Noninvasive prenatal testing identifies twice as many Down syndrome cases as second-trimester serum screening
A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum screening (STSS) in accuracy and cost-effectiveness, as NIPT identifies twice as many DS cases as STSS.
👉 Full Story
Car Crash Turns Into Wild Street Fight Between Black Women!
- Poll reveals some parents say they waited too long to stop pacifier use or thumb-sucking in children
- Calorie Restriction: A Potential Pathway to Slow Brain Aging? - Arya Chandran
- Reduce model integration costs while scaling AI: LangChain’s open ecosystem delivers where closed vendors can’t - Emilia David
- ProtonVPN deal: Get 66 percent off two-year subscriptions - Lawrence Bonk
- ECU Health expands Health Sciences Academy to four new locations - Jerry.Grimes@ecuhealth.org
- Meghan Markle hits back in row over use of HRH title after agreement with late Queen - Isaiah Amos
Important! Do These 3 Things Now..
- Surveys show best and worst Mother's Day gifts
- New adults-only experience coming to Disney World
- Dad wins $5.46M after telling family 'that money is going to be mine'
- The 2023 Geminid Meteor Shower: A Spectacular Sky Show - Arya Chandran
- VP Vance, Ukraine's Zelensky Meet in Rome, and Zelensky Waxes Rhapsodic on Negotiations Without Russia
- Why the Biden Health Cover-Up Really Matters - John Fund
